Viewing Study NCT02109328


Ignite Creation Date: 2025-12-26 @ 11:11 AM
Ignite Modification Date: 2026-03-02 @ 8:18 AM
Study NCT ID: NCT02109328
Status: COMPLETED
Last Update Posted: 2019-04-11
First Post: 2014-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Alisertib in Chemotherapy-pretreated Urothelial Cancer
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: UC-Aurora_INT01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators